Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
VirionHealth is a biotechnology company
Kesios Therapeutics, a London, UK-based oncology drug discovery company
Abingworth has invested in 50 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Abingworth's top investment sectors include Biotechnology, Therapeutics, Pharmaceutical, Health Care, Medical. The firm invests across 6 different industry categories.
Among tracked funding rounds, VirionHealth received $17.2M in a Series A round. Abingworth's total known invested capital is $5.2B.
Abingworth's average investment size is $126.9M across its portfolio of 50 companies.